David B. Weiner - 15 May 2024 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ David B. Weiner
Issuer symbol
INO
Transactions as of
15 May 2024
Transactions value $
$0
Form type
4
Filing time
16 May 2024, 17:05:26 UTC
Previous filing
28 Feb 2024
Next filing
22 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +2.17K +2.7% 82.5K 15 May 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -2.17K -100% $0.00* 0 15 May 2024 Common Stock 2.17K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 15, 2024.
F2 Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.